Seresto Antiparasitic Collar Large Dogs >8kg

Antiparasitic Collar Seresto Large Dog (>8Kg)

Recent studies show effectiveness Seresto collar preventing Leishmaniosis

Study Leishmaniosis Seresto

Medium and Large Dogs (> 8kg)

Composition: 1 Necklace (70 cm) dog Seresto> 8 kg contains: 4.50 g and 2.03 g of imidacloprid flumethrin.

Indications:

For the prevention and treatment of flea infestation (Ctenocephalides felis, C. canis) for 7 - 8 months. It protects the immediate environment of the animal by inhibiting the development of flea larvae for 8 months.

Seresto can be used as part of a treatment strategy for allergic dermatitis caused by flea bites (DAPP).

The veterinary drug is effective against tick infestations for 8 months for its repellent effect (anti-feeding) (Ixodes ricinus, Rhipicephalus sanguineus) and its acaricidal effect (death of the parasite) (Ixodes ricinus, Rhipicephalus sanguineus, Dermacentor reticulatus). It is effective against adult larvae, nymphs and ticks.

Ticks present in the dog before treatment may not die in the first 48 hours after application of the collar, so they may remain attached and visible. Therefore, it is recommended to remove existing ticks in the dog prior to the application of the collar. The prevention of new infestations by ticks starts during the first two days after the application of the collar.

The collar indirectly protects against the transmission of the pathogens Babesia canis vogeli and Ehrlichia canis by the tick Rhiphicephalus sanguineus and consequently, the risk of canine babesiosis and canine ehrlichiosis is decreased for 7 months.

Reduction of the risk of infection by Leishmania infantum through transmission by sandflies up to 8 months.

For the treatment of infestation by biting / chewing lice (Trichodectes canis).

Posology and method of administration

Cutaneous use. One collar per animal to apply around the neck.
Dogs weighing more than 8 kg must wear a 70 cm long collar.
Small dogs up to 8 kg must wear a collar for dogs <8 kg of 38 cm in length.

Remove the collar from the protective bag just before use. Unroll the collar and make sure that there are no remains of the plastic strips on the inside of the collar. Adjust the collar loosely around the neck of the animal (it is recommended to leave a space of two fingers between the collar and neck). Pass the end of the collar through the buckles. Cut the excess collar leaving 2 cm behind the buckle.

The dog must wear the collar continuously during the 8 month period of protection. The collar should be removed at the end of the treatment. Check the collar periodically and adjust if necessary, especially in puppies with rapid growth.

Do not treat puppies under 7 weeks.

In the absence of available data, the veterinary drug is not recommended in gestating or lactating bitches.

Do not use in case of hypersensitivity to the active substances or to any excipient.

Collar of 70cm.

  Monografía

Bayer is a multinational company with key competencies in the fields of health, nutrition and high-performance materials. With our products and services we want to be useful to humanity and contribute to improve health and quality of life. Bayer's statement of principles is summarized in the slogan "Bayer: Science For A Better Life" and in the continuous improvement of our products.

Bayer HealthCare (BHC) is the subsidiary of the Bayer Group that groups the divisions:

- Animal Health

- Consumer Care

- Medical Care

- Pharma

Its objective is the research, development, production and marketing of innovative products that improve the health of people and animals around the world.

The Animal Health division of Bayer is composed of two areas, focused on the two fundamental markets of the veterinary sector: pets and production animals.

The CAP (Companion Animal Products) area markets products for the prevention, care and health of pets, especially dogs and cats.

The Department of FAP (Farm Animal Products) is dedicated to the commercialization of products for production animals, mainly for pigs and ruminants, and also develops biosecurity programs that reduce the activity of pathogenic organisms in farms.

The commitment of this division is to offer the veterinary sector products that improve the health and quality of life of pets, as well as greater productivity in supply animals. In addition, the Animal Health division has an extensive program of corporate social responsibility actions, such as support for different programs of animal-assisted therapies, and the promotion of adoption and the fight against abandonment. These activities reinforce the social commitment of the Animal Health division, in line with Bayer's values ​​of research for a better life.